ICL Reports Third Quarter 2024 Results
ICL reported Q3 2024 financial results with consolidated sales of $1.75 billion, down from $1.86 billion year-over-year. The company achieved adjusted EBITDA of $383 million, up from $346 million, marking four consecutive quarters of improvement. Adjusted diluted EPS was $0.11, unchanged from the previous year. The company raised its full-year 2024 guidance for specialties-driven EBITDA to $0.95-1.05 billion, up from previous guidance of $0.8-1.0 billion. ICL plans to limit annual potash sales volumes to 4.6 million metric tons, maintaining levels consistent with 2023.
ICL ha riportato i risultati finanziari del terzo trimestre 2024 con vendite consolidate di $1,75 miliardi, in calo rispetto a $1,86 miliardi rispetto allo stesso periodo dell'anno precedente. L'azienda ha ottenuto un EBITDA rettificato di $383 milioni, in aumento rispetto a $346 milioni, segnando quattro trimestri consecutivi di miglioramento. L'EPS diluito rettificato è stato di $0,11, invariato rispetto all'anno precedente. L'azienda ha aumentato le previsioni per l'intero anno 2024 per l'EBITDA trainato da specialità a $0,95-1,05 miliardi, in aumento rispetto alle previsioni precedenti di $0,8-1,0 miliardi. ICL prevede di limitare i volumi annuali di vendite di potassa a 4,6 milioni di tonnellate metriche, mantenendo livelli coerenti con il 2023.
ICL informó los resultados financieros del tercer trimestre de 2024 con ventas consolidadas de $1.75 mil millones, una disminución de $1.86 mil millones en comparación con el año anterior. La empresa logró un EBITDA ajustado de $383 millones, un aumento desde $346 millones, marcando cuatro trimestres consecutivos de mejora. El EPS diluido ajustado fue de $0.11, sin cambios respecto al año anterior. La empresa elevó su guía para el EBITDA impulsado por especialidades para todo 2024 a $0.95-1.05 mil millones, en comparación con la guía anterior de $0.8-1.0 mil millones. ICL planea limitar los volúmenes anuales de ventas de potasa a 4.6 millones de toneladas métricas, manteniendo niveles consistentes con 2023.
ICL는 2024년 3분기 재무 결과를 보고하며 통합 판매액이 17억 5천만 달러로 전년 동기 대비 18억 6천만 달러에서 감소했다고 밝혔다. 회사는 조정된 EBITDA가 3억 8천 3백만 달러로 증가하여 3억 4천 6백만 달러에서 증가했으며, 이는 4분기 연속 개선을 나타냅니다. 조정된 희석 EPS는 $0.11로 전년과 동일했습니다. 회사는 2024년 전체에 대한 특수 물질에 의해 주도되는 EBITDA 목표를 이전의 $0.8-1.0억 달러에서 $0.95-1.05억 달러로 상향 조정했습니다. ICL은 연간 칼리 판매량을 460만 미터 톤으로 제한할 계획이며, 이는 2023년과 일치하는 수준을 유지합니다.
ICL a annoncé les résultats financiers du troisième trimestre 2024 avec des ventes consolidées de 1,75 milliard $, en baisse par rapport à 1,86 milliard $ par rapport à l'année précédente. L'entreprise a réalisé un EBITDA ajusté de 383 millions $, en hausse par rapport à 346 millions $, marquant ainsi quatre trimestres consécutifs d'amélioration. Le BPA dilué ajusté était de 0,11 $, inchangé par rapport à l'année précédente. L'entreprise a relevé ses prévisions pour l'EBITDA tiré des spécialités pour l'ensemble de l'année 2024 à 0,95-1,05 milliard $, contre les prévisions précédentes de 0,8-1,0 milliard $. ICL prévoit de limiter les volumes de ventes annuels de potasse à 4,6 millions de tonnes métriques, maintenant des niveaux conformes à ceux de 2023.
ICL berichtete über die Finanzergebnisse des dritten Quartals 2024 mit konsolidierten Verkaufszahlen von 1,75 Milliarden Dollar, ein Rückgang von 1,86 Milliarden Dollar im Jahresvergleich. Das Unternehmen erzielte ein bereinigtes EBITDA von 383 Millionen Dollar, ein Anstieg von 346 Millionen Dollar, was vier aufeinanderfolgende Quartale der Verbesserung markiert. Der bereinigte verwässerte EPS betrug $0,11, unverändert im Vergleich zum Vorjahr. Das Unternehmen hat seine Gesamten Prognose für 2024 bezüglich des spezialitätengetriebenen EBITDA auf 0,95-1,05 Milliarden Dollar angehoben, verglichen mit der vorherigen Prognose von 0,8-1,0 Milliarden Dollar. ICL plant, die jährlichen Verkaufsvolumen von Kalium auf 4,6 Millionen metrische Tonnen zu begrenzen, um ein Niveau zu halten, das konsistent mit 2023 ist.
- Adjusted EBITDA increased to $383M from $346M YoY
- Raised full-year specialties-driven EBITDA guidance to $0.95-1.05B
- Gross margin improved to 34% from 31% YoY
- Industrial Products sales grew to $309M from $267M YoY
- Growing Solutions EBITDA increased by 70% YoY to $64M
- Sales declined to $1.75B from $1.86B YoY
- Operating income decreased to $214M from $227M YoY
- Potash sales dropped to $389M from $526M YoY
- Potash sales volume decreased by 220,000 metric tons YoY
- Net income declined to $113M from $137M YoY
Insights
ICL's Q3 2024 results show mixed performance with some notable strengths. Sales declined -5.9% year-over-year to
Key positives include sequential EBITDA growth for four consecutive quarters and strong performance in specialty segments. However, challenges persist in the potash segment, where sales dropped significantly from
The balance sheet remains solid with
The commodities market context significantly impacts ICL's performance. The Grain Price Index's -19.6% decline year-over-year, with substantial drops in corn (
The strategic focus on battery materials, particularly expansion in China and South America, positions ICL well in growing markets. The upcoming U.S. customer innovation center completion could strengthen market position in North America. The company's ability to maintain margins through cost management and efficiency improvements, despite lower prices, demonstrates operational resilience.
Continued to deliver sequential growth, with sales of
Raising guidance for specialties-driven businesses
“ICL delivered another sequential increase in EBITDA, as well as versus the prior year, marking four consecutive quarters of improvement, despite lower potash prices. All three of our specialties-driven businesses showed significant year-over-year improvement in EBITDA, demonstrating the strength of our strategy and our ability to consistently deliver strong cash generation,” said Raviv Zoller, president and CEO of ICL. “While we are still facing some challenges related to geopolitical uncertainties, we remain focused on developing our innovative product portfolio pipeline and executing targeted cost and efficiency efforts.”
The company raised its guidance for full year 2024 and now expects specialties-driven EBITDA of between
Key Financials
Third Quarter 2024
US$M Ex. per share data |
3Q'24 |
3Q'23 |
Sales |
|
|
Gross profit |
|
|
Gross margin |
|
|
Operating income |
|
|
Adjusted operating income (1) |
|
|
Operating margin |
|
|
Adjusted operating margin (1) |
|
|
Net income attributable to shareholders |
|
|
Adjusted net income attributable to shareholders (1) |
|
|
Adjusted EBITDA (1)(2) |
|
|
Adjusted EBITDA margin (1)(2) |
|
|
Diluted earnings per share |
|
|
Diluted adjusted earnings per share (1) |
|
|
Cash flows from operating activities (3) |
|
|
(1) |
Adjusted operating income and margin, adjusted net income attributable to shareholders, adjusted EBITDA and margin, and diluted adjusted earnings per share are non-GAAP financial measures. Please refer to the adjustments table and disclaimer. |
(2) |
In the nine months of 2024, the company’s adjusted EBITDA was positively impacted by an immaterial accounting reclassification. Please refer to the 6-K filing for additional details. |
(3) |
Reclassified - see Note 2 to the company's interim financial statements. |
Industrial Products
Third quarter 2024
-
Sales of
vs.$309 million .$267 million -
EBITDA of
vs.$65 million .$42 million - Year-over-year growth driven by market share gains in flame retardants.
Key developments versus prior year
- Flame retardants: Sales increased, as higher volumes for both brominated- and phosphorous-based solutions offset lower prices overall, while demand from both the electronics and construction end-markets remained soft.
- Elemental bromine: Higher volumes drove an increase in sales, offsetting lower prices.
-
Clear brine fluids: Sales declined, despite strength in the Gulf of
Mexico , as oil and gas demand in the Eastern Hemisphere was lower, due to the normal pattern of the drilling operations cycle. - Specialty minerals: Increased sales were driven by higher volumes for industrial applications, while prices were lower.
Potash
Third quarter 2024
-
Sales of
vs.$389 million .$526 million -
EBITDA of
vs.$120 million .$164 million -
Grain Price Index decreased
19.6% year-over-year, with corn, rice, soybeans and wheat down27.2% ,4.3% ,26.4% and29.0% , respectively. On a sequential basis, the Grain Price Index decreased14.3% , with corn, rice, soybeans and wheat down11.5% ,16.4% ,11.9% and14.1% , respectively.
Key developments versus prior year
-
Potash price:
per ton (CIF).$297 -
Down
1% sequentially and13% year-over-year.
-
Down
-
Potash sales volumes: 1,060 thousand metric tons.
- Decreased by 220 thousand metric tons year-over-year.
-
ICL Dead Sea
- Production decreased, primarily due to external forces.
-
ICL Iberia
- Record third quarter production, with continued operational and efficiency improvements.
-
Metal Magnesium
- Both volumes and prices declined, as market prices continued to trend lower.
Phosphate Solutions
Third quarter 2024
-
Sales of
vs.$577 million .$595 million -
EBITDA of
vs.$140 million .$118 million -
Third sequential quarter of sales growth, with EBITDA up nearly
20% year-over-year.
Key developments versus prior year
-
White phosphoric acid: Sales decreased, as higher volumes in most regions were unable to offset lower prices in
Europe , as well as inNorth and South America . - Industrial phosphates: Sales increased, as higher volumes in all major regions offset lower prices related to decreasing cost inputs.
- Food phosphates: Despite higher volumes, sales decreased due to lower market prices, which reflected reduced raw material costs.
-
Battery materials:
China sales increased, as market demand expanded there. Elsewhere, the company continued to execute on its long-term battery materials strategy, with theU.S. customer innovation and qualification center (CIQC) on-track for completion by year-end. The business also expanded intoSouth America , with the addition of a new customer. - Commodity phosphates: Overall phosphate prices firmed in the third quarter, with tight stock positions in key markets, strategic allocation decisions and prevailing policies.
Growing Solutions
Third quarter 2024
-
Sales of
vs.$538 million .$550 million -
EBITDA of
vs.$64 million .$37 million -
Third sequential quarter of sales and EBITDA growth, with EBITDA up more than
70% year-over-year.
Key developments versus prior year
-
Brazil : Sales declined, due to exchange rate fluctuations, but higher prices and lower raw material costs drove an increase in gross profit. -
Europe : Sales decreased, but gross profit increased on higher volumes and lower raw material costs. -
North America : Sales increased, with higher volumes and slightly higher prices contributing to increased gross profit. -
Asia : Sales increased, and higher volumes, prices and product mix drove higher gross profit. -
Product trends: Specialty agriculture sales decreased, as exchange rate fluctuations, mainly in
Brazil , and lower sales volumes inChina offset higher prices. Turf and ornamental sales increased, with both turf and landscape and ornamental horticulture contributing.
Financial Items
Financing Expenses
Net financing expenses for the third quarter of 2024 were
Tax Expenses
Reported tax expenses in the third quarter of 2024 were
Available Liquidity
ICL’s available cash resources, which are comprised of cash and deposits, unutilized revolving credit facility, and unutilized securitization, totaled
Outstanding Net Debt
As of September 30, 2024, ICL’s net financial liabilities amounted to
Dividend Distribution
In connection with ICL’s third quarter 2024 results, the Board of Directors declared a dividend of
About ICL
ICL Group Ltd. is a leading global specialty minerals company, which creates impactful solutions for humanity's sustainability challenges in the food, agriculture and industrial markets. ICL leverages its unique bromine, potash and phosphate resources, its global professional workforce, and its sustainability focused R&D and technological innovation capabilities, to drive the company's growth across its end markets. ICL shares are dual listed on the New York Stock Exchange and the Tel Aviv Stock Exchange (NYSE and TASE: ICL). The company employs more than 12,000 people worldwide, and its 2023 revenue totaled approximately
For more information, including ICL’s full third quarter financial statements and report, visit ICL’s website at icl-group.com, and also the SEC’s EDGAR website, once it reopens on November 12, 2024.
To access ICL's interactive CSR report, visit icl-group-sustainability.com.
You can also learn more about ICL on Facebook, LinkedIn, YouTube, X and Instagram.
Guidance
(1a) The company only provides guidance on a non-GAAP basis. The company does not provide a reconciliation of forward-looking adjusted EBITDA (non-GAAP) to GAAP net income (loss), due to the inherent difficulty in forecasting, and quantifying certain amounts that are necessary for such reconciliation, in particular, because special items such as restructuring, litigation, and other matters, used to calculate projected net income (loss) vary dramatically based on actual events, the company is not able to forecast on a GAAP basis with reasonable certainty all deductions needed in order to provide a GAAP calculation of projected net income (loss) at this time. The amount of these deductions may be material, and therefore could result in projected GAAP net income (loss) being materially less than projected adjusted EBITDA (non-GAAP). The guidance speaks only as of the date hereof. The company undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law. The company provides guidance for specialties-driven EBITDA, which includes Industrial Products, Growing Solutions and Phosphate Solutions, as the Phosphate Solutions business is now predominantly specialties focused. For the Potash business, the company is providing sales volume guidance. The company believes this information provides greater transparency, as these new metrics are less impacted by fertilizer commodity prices, given the extreme volatility in recent years.
Non-GAAP Statement
The company discloses in this quarterly report non-IFRS financial measures titled adjusted operating income, adjusted net income attributable to the company’s shareholders, diluted adjusted earnings per share, and adjusted EBITDA. Management uses adjusted operating income, adjusted net income attributable to the company’s shareholders, diluted adjusted earnings per share, and adjusted EBITDA to facilitate operating performance comparisons from period to period. The company calculates adjusted operating income by adjusting operating income to add certain items, as set forth in the reconciliation table under “Adjustments to reported operating, and net income (non-GAAP)” below. Certain of these items may recur. The company calculates adjusted net income attributable to the company’s shareholders by adjusting net income attributable to the company’s shareholders to add certain items, as set forth in the reconciliation table under “Adjustments to reported operating, and net income (non-GAAP)” below, excluding the total tax impact of such adjustments. The company calculates diluted adjusted earnings per share by dividing adjusted net income by the weighted-average number of diluted ordinary shares outstanding. Adjusted EBITDA is calculated as net income before financing expenses, net, taxes on income, share in earnings of equity-accounted investees, depreciation and amortization, and certain adjustments presented in the reconciliation table under “Consolidated adjusted EBITDA, and diluted adjusted earnings per share for the periods of activity” below, which were adjusted for in calculating the adjusted operating income.
You should not view adjusted operating income, adjusted net income attributable to the company’s shareholders, diluted adjusted earnings per share or adjusted EBITDA as a substitute for operating income or net income attributable to the company’s shareholders determined in accordance with IFRS, and you should note that the company’s definitions of adjusted operating income, adjusted net income attributable to the company’s shareholders, diluted adjusted earnings per share, and adjusted EBITDA may differ from those used by other companies. Additionally, other companies may use other measures to evaluate their performance, which may reduce the usefulness of the company’s non-IFRS financial measures as tools for comparison. However, the company believes adjusted operating income, adjusted net income attributable to the company’s shareholders, diluted adjusted earnings per share, and adjusted EBITDA provide useful information to both management, and investors by excluding certain items that management believes are not indicative of ongoing operations. Management uses these non-IFRS measures to evaluate the company's business strategies and management performance. The company believes these non‑IFRS measures provide useful information to investors because they improve the comparability of financial results between periods and provide for greater transparency of key measures used to evaluate performance.
The company presents a discussion in the period-to-period comparisons of the primary drivers of change in the company’s results of operations. This discussion is based in part on management’s best estimates of the impact of the main trends on the company’s businesses. The company has based the following discussion on its financial statements. You should read such discussion together with the company’s financial statements.
Forward Looking Statements
This announcement contains statements that constitute “forward‑looking statements,” many of which can be identified by the use of forward‑looking words such as “anticipate,” “believe,” “could,” “expect,” “should,” “plan,” “intend,” “estimate,” “strive,” “forecast,” “targets” and “potential,” among others. The company is relying on the safe harbor provided in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, in making such forward-looking statements.
Forward‑looking statements appear in a number of places in this announcement and include, but are not limited to, statements regarding intent, belief or current expectations. Forward‑looking statements are based on management’s beliefs and assumptions and on information currently available to management. Such statements are subject to risks and uncertainties and actual results may differ materially from those expressed or implied in the forward‑looking statements due to various factors, including, but not limited to:
Loss or impairment of business licenses or mineral extractions permits or concessions; volatility of supply and demand and the impact of competition; the difference between actual reserves and reserve estimates; natural disasters and cost of compliance with environmental regulatory legislative and licensing restrictions including laws and regulation related to, and physical impacts of climate change and greenhouse gas emissions; failure to "harvest" salt which could lead to accumulation of salt at the bottom of the evaporation Pond 5 in the Dead Sea; litigation, arbitration and regulatory proceedings; disruptions at seaport shipping facilities or regulatory restrictions affecting the ability to export products overseas; changes in exchange rates or prices compared to those the company is currently experiencing; general market, political or economic conditions in the countries in which the company operates; price increases or shortages with respect to principal raw materials; pandemics may create disruptions, impacting sales, operations, supply chain and customers; delays in termination of engagements with contractors and/or governmental obligations; the inflow of significant amounts of water into the Dead Sea which could adversely affect production at the plants; labor disputes, slowdowns and strikes involving employees; pension and health insurance liabilities; changes to governmental incentive programs or tax benefits, creation of new fiscal or tax related legislation; and/or higher tax liabilities; changes in evaluations and estimates, which serve as a basis for the recognition and manner of measurement of assets and liabilities; failure to integrate or realize expected benefits from mergers and acquisitions, organizational restructuring and joint ventures; currency rate fluctuations; rising interest rates; government examinations or investigations; information technology systems or breaches of the company, or its service providers', data security; failure to retain and/or recruit key personnel; inability to realize expected benefits from the company’s cost reduction program according to the expected timetable; inability to access capital markets on favorable terms; cyclicality of the businesses; the company is exposed to risks relating to its current and future activity in emerging markets; changes in demand for its fertilizer products due to a decline in agricultural product prices, lack of available credit, weather conditions, government policies or other factors beyond the company’s control; disruption of the company, or its service providers', sales of magnesium products being affected by various factors that are not within the company’s control; volatility or crises in the financial markets; hazards inherent to mining and chemical manufacturing; the failure to ensure the safety of the company’s workers and processes; exposure to third party and product liability claims; product recalls or other liability claims as a result of food safety and food-borne illness concerns; insufficiency of insurance coverage; war or acts of terror and/or political, economic and military instability in
Forward‑looking statements speak only as of the date they are made, and, except as otherwise required by law, the company does not undertake any obligation to update them in light of new information or future developments or to release publicly any revisions to these statements, targets or goals in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events. Investors are cautioned to consider these risk and uncertainties and to not place undue reliance on such information. Forward-looking statements should not be read as a guarantee of future performance or results and are subject to risks and uncertainties, and the actual results may differ materially from those expressed or implied in the forward-looking statements.
This report for the third quarter of 2024 should be read in conjunction with the Annual Report of 2023 published by the company on Form 20-F and the report for the first and second quarters of 2024 published by the company, including the description of events occurring subsequent to the date of the statement of financial position, as filed with the US SEC.
Appendix
Condensed Consolidated Statements of Income (Unaudited)
$ millions |
Three-months ended |
Nine-months ended |
Year ended |
|||||||
|
September 30,
|
September 30,
|
September 30,
|
September 30,
|
December 31,
|
|||||
Sales |
1,753 |
1,862 |
5,240 |
5,846 |
7,536 |
|||||
Cost of sales |
1,157 |
1,276 |
3,519 |
3,735 |
4,865 |
|||||
|
|
|
|
|
|
|||||
Gross profit |
596 |
586 |
1,721 |
2,111 |
2,671 |
|||||
|
|
|
|
|
|
|||||
Selling, transport and marketing expenses |
280 |
264 |
833 |
807 |
1,093 |
|||||
General and administrative expenses |
63 |
66 |
191 |
189 |
260 |
|||||
Research and development expenses |
19 |
17 |
50 |
54 |
71 |
|||||
Other expenses |
22 |
14 |
27 |
84 |
128 |
|||||
Other income |
(2) |
(2) |
(8) |
(15) |
(22) |
|||||
|
|
|
|
|
|
|||||
Operating income |
214 |
227 |
628 |
992 |
1,141 |
|||||
|
|
|
|
|
|
|||||
Finance expenses |
46 |
79 |
166 |
255 |
259 |
|||||
Finance income |
(7) |
(37) |
(59) |
(120) |
(91) |
|||||
Finance expenses, net |
39 |
42 |
107 |
135 |
168 |
|||||
|
|
|
|
|
|
|||||
Share in earnings of equity-accounted investees |
1 |
- |
1 |
- |
1 |
|||||
|
|
|
|
|
|
|||||
Income before taxes on income |
176 |
185 |
522 |
857 |
974 |
|||||
|
|
|
|
|
|
|||||
Taxes on income |
49 |
43 |
139 |
254 |
287 |
|||||
|
|
|
|
|
|
|||||
Net income |
127 |
142 |
383 |
603 |
687 |
|||||
|
|
|
|
|
|
|||||
Net income attributable to the non-controlling interests |
14 |
5 |
46 |
23 |
40 |
|||||
|
|
|
|
|
|
|||||
Net income attributable to the shareholders of the Company |
113 |
137 |
337 |
580 |
647 |
|||||
|
|
|
|
|
|
|||||
Earnings per share attributable to the shareholders of the Company: |
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
Basic earnings per share (in dollars) |
0.09 |
0.11 |
0.26 |
0.45 |
0.50 |
|||||
|
|
|
|
|
|
|||||
Diluted earnings per share (in dollars) |
0.09 |
0.11 |
0.26 |
0.45 |
0.50 |
|||||
|
|
|
|
|
|
|||||
Weighted-average number of ordinary shares outstanding: |
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
Basic (in thousands) |
1,290,171 |
1,289,318 |
1,289,869 |
1,289,332 |
1,289,361 |
|||||
|
|
|
|
|
|
|||||
Diluted (in thousands) |
1,290,371 |
1,290,813 |
1,290,094 |
1,290,926 |
1,290,668 |
|||||
Condensed Consolidated Statements of Financial Position as of (Unaudited)
$ millions |
September 30, 2024 |
September 30, 2023 |
December 31, 2023 |
|||
Current assets |
|
|
|
|||
Cash and cash equivalents |
393 |
307 |
420 |
|||
Short-term investments and deposits |
110 |
162 |
172 |
|||
Trade receivables |
1,393 |
1,387 |
1,376 |
|||
Inventories |
1,591 |
1,722 |
1,703 |
|||
Prepaid expenses and other receivables |
337 |
362 |
363 |
|||
Total current assets |
3,824 |
3,940 |
4,034 |
|||
|
|
|
|
|||
Non-current assets |
|
|
|
|||
Deferred tax assets |
149 |
141 |
152 |
|||
Property, plant and equipment |
6,414 |
6,125 |
6,329 |
|||
Intangible assets |
916 |
851 |
873 |
|||
Other non-current assets |
255 |
217 |
239 |
|||
Total non-current assets |
7,734 |
7,334 |
7,593 |
|||
|
|
|
|
|||
Total assets |
11,558 |
11,274 |
11,627 |
|||
|
|
|
|
|||
Current liabilities |
|
|
|
|||
Short-term debt |
606 |
592 |
858 |
|||
Trade payables |
921 |
814 |
912 |
|||
Provisions |
49 |
71 |
85 |
|||
Other payables |
874 |
809 |
783 |
|||
Total current liabilities |
2,450 |
2,286 |
2,638 |
|||
|
|
|
|
|||
Non-current liabilities |
|
|
|
|||
Long-term debt and debentures |
1,845 |
1,984 |
1,829 |
|||
Deferred tax liabilities |
495 |
464 |
489 |
|||
Long-term employee liabilities |
339 |
334 |
354 |
|||
Long-term provisions and accruals |
223 |
234 |
224 |
|||
Other |
71 |
64 |
56 |
|||
Total non-current liabilities |
2,973 |
3,080 |
2,952 |
|||
|
|
|
|
|||
Total liabilities |
5,423 |
5,366 |
5,590 |
|||
|
|
|
|
|||
Equity |
|
|
|
|||
Total shareholders’ equity |
5,873 |
5,664 |
5,768 |
|||
Non-controlling interests |
262 |
244 |
269 |
|||
Total equity |
6,135 |
5,908 |
6,037 |
|||
|
|
|
|
|||
Total liabilities and equity |
11,558 |
11,274 |
11,627 |
|||
Condensed Consolidated Statements of Cash Flows (Unaudited)
$ millions |
Three-months ended |
Nine-months ended |
Year ended |
|||||||
|
September 30,
|
September 30,
|
September 30,
|
September 30,
|
December 31, 2023 |
|||||
Cash flows from operating activities |
|
|
|
|
|
|||||
Net income |
127 |
142 |
383 |
603 |
687 |
|||||
Adjustments for: |
|
|
|
|
|
|||||
Depreciation and amortization |
140 |
119 |
439 |
390 |
536 |
|||||
Fixed assets impairment |
7 |
- |
7 |
- |
- |
|||||
Exchange rate, interest and derivative, net |
9 |
27 |
105 |
75 |
24 |
|||||
Tax expenses |
49 |
43 |
139 |
254 |
287 |
|||||
Change in provisions |
- |
(13) |
(53) |
(41) |
(32) |
|||||
Other |
2 |
1 |
6 |
7 |
29 |
|||||
|
207 |
177 |
643 |
685 |
844 |
|||||
|
|
|
|
|
|
|||||
Change in inventories |
(14) |
251 |
95 |
415 |
465 |
|||||
Change in trade receivables |
73 |
(28) |
(42) |
205 |
252 |
|||||
Change in trade payables |
46 |
(59) |
17 |
(167) |
(101) |
|||||
Change in other receivables |
(31) |
(6) |
(27) |
(11) |
26 |
|||||
Change in other payables |
22 |
(19) |
4 |
(226) |
(210) |
|||||
Net change in operating assets and liabilities |
96 |
139 |
47 |
216 |
432 |
|||||
|
|
|
|
|
|
|||||
Income taxes paid, net of refund |
(22) |
(32) |
(57) |
(246) |
(253) |
|||||
|
|
|
|
|
|
|||||
Net cash provided by operating activities (*) |
408 |
426 |
1,016 |
1,258 |
1,710 |
|||||
|
|
|
|
|
|
|||||
Cash flows from investing activities |
|
|
|
|
|
|||||
Proceeds (payments) from deposits, net |
- |
1 |
61 |
(78) |
(88) |
|||||
Purchases of property, plant and equipment and intangible assets |
(159) |
(191) |
(446) |
(525) |
(780) |
|||||
Interest received (*) |
4 |
2 |
14 |
7 |
10 |
|||||
Proceeds from divestiture of assets and businesses, net of transaction expenses |
1 |
1 |
19 |
4 |
4 |
|||||
Business combinations |
(50) |
- |
(72) |
- |
- |
|||||
Other |
- |
- |
- |
1 |
1 |
|||||
Net cash used in investing activities |
(204) |
(187) |
(424) |
(591) |
(853) |
|||||
|
|
|
|
|
|
|||||
Cash flows from financing activities |
|
|
|
|
|
|||||
Dividends paid to the Company's shareholders |
(63) |
(82) |
(183) |
(406) |
(474) |
|||||
Receipts of long-term debt |
273 |
131 |
611 |
484 |
633 |
|||||
Repayments of long-term debt |
(307) |
(255) |
(919) |
(653) |
(836) |
|||||
Receipts (Repayments) of short-term debt |
8 |
(72) |
7 |
(89) |
(25) |
|||||
Interest paid (*) |
(16) |
(21) |
(79) |
(85) |
(125) |
|||||
Receipts (payments) from transactions in derivatives |
(2) |
- |
1 |
6 |
5 |
|||||
Dividend paid to the non-controlling interests |
- |
- |
(57) |
(15) |
(15) |
|||||
Net cash used in financing activities |
(107) |
(299) |
(619) |
(758) |
(837) |
|||||
|
|
|
|
|
|
|||||
Net change in cash and cash equivalents |
97 |
(60) |
(27) |
(91) |
20 |
|||||
Cash and cash equivalents as of the beginning of the period |
287 |
372 |
420 |
417 |
417 |
|||||
Net effect of currency translation on cash and cash equivalents |
9 |
(5) |
- |
(19) |
(17) |
|||||
Cash and cash equivalents as of the end of the period |
393 |
307 |
393 |
307 |
420 |
|||||
(*) Reclassified - see Note 2 to the Company's Interim Financial Statements. |
Adjustments to Reported Operating and Net Income (non-GAAP)
$ millions |
Three-months ended |
Nine-months ended |
||||||
September 30,
|
September 30,
|
September 30,
|
September 30,
|
|||||
Operating income |
214 |
227 |
628 |
992 |
||||
Charges related to the security situation in |
14 |
- |
40 |
- |
||||
Write-off of assets and provision for site closure (2) |
15 |
- |
15 |
15 |
||||
Total adjustments to operating income |
29 |
- |
55 |
15 |
||||
Adjusted operating income |
243 |
227 |
683 |
1,007 |
||||
Net income attributable to the shareholders of the Company |
113 |
137 |
337 |
580 |
||||
Total adjustments to operating income |
29 |
- |
55 |
15 |
||||
Total tax adjustments (3) |
(6) |
- |
(12) |
(3) |
||||
Total adjusted net income - shareholders of the Company |
136 |
137 |
380 |
592 |
||||
(1) |
For 2024, reflects charges relating to the security situation in |
(2) |
For 2024, reflects mainly a write-off of assets resulting from the closure of two small sites. For 2023, reflects mainly a write-off of assets related to restructuring at certain sites, including site closures and facility modifications, as part of the Company’s global efficiency plan. |
(3) |
For 2024 and 2023, reflects the tax impact of adjustments made to operating income. |
Consolidated EBITDA for the Periods of Activity
$ millions |
Three-months ended |
Nine-months ended |
||||||
|
September 30,
|
September 30,
|
September 30,
|
September 30,
|
||||
Net income |
127 |
142 |
383 |
603 |
||||
Financing expenses, net |
39 |
42 |
107 |
135 |
||||
Taxes on income |
49 |
43 |
139 |
254 |
||||
Less: Share in earnings of equity-accounted investees |
(1) |
- |
(1) |
- |
||||
Operating income |
214 |
227 |
628 |
992 |
||||
Depreciation and amortization |
140 |
119 |
439 |
390 |
||||
Adjustments (1) |
29 |
- |
55 |
15 |
||||
Total adjusted EBITDA (2) |
383 |
346 |
1,122 |
1,397 |
||||
(1) |
See "Adjustments to Reported Operating and Net income (non-GAAP)" above. |
(2) |
In the first nine months of 2024, the Company’s adjusted EBITDA was positively impacted by an immaterial accounting reclassification. Please refer to the 6-K filing for additional details. |
Calculation of Segment EBITDA
$ millions |
Industrial Products |
Potash |
Phosphate Solutions (1) |
Growing Solutions |
||||||||||||
|
Three-months ended |
|||||||||||||||
|
September 30,
|
September 30,
|
September 30,
|
September 30,
|
September 30,
|
September 30,
|
September 30,
|
September 30,
|
||||||||
Segment operating income |
50 |
31 |
59 |
125 |
100 |
73 |
49 |
20 |
||||||||
Depreciation and amortization |
15 |
11 |
61 |
39 |
40 |
45 |
15 |
17 |
||||||||
Segment EBITDA |
65 |
42 |
120 |
164 |
140 |
118 |
64 |
37 |
||||||||
(1) |
In alignment with the Company’s efficiency plan, which includes a change of reporting responsibilities as of January 2024, the results of a non-phosphate related business were allocated from the Phosphate Solutions segment to Other Activities. Comparative figures have been restated to reflect the organizational change in the reportable segments. |
(2) |
For Q3 2024, Phosphate Specialties comprised |
View source version on businesswire.com: https://www.businesswire.com/news/home/20241110145727/en/
Investor and Press Contact – Global
Peggy Reilly Tharp
VP, Global Investor Relations
+1-314-983-7665
Peggy.ReillyTharp@icl-group.com
Investor and Press Contact -
Adi Bajayo
ICL Spokesperson
+972-3-6844459
Adi.Bajayo@icl-group.com
Source: ICL Group LTD
FAQ
What was ICL's Q3 2024 revenue and how did it compare to last year?
How much did ICL raise its 2024 specialties-driven EBITDA guidance?
What was ICL's adjusted EBITDA in Q3 2024?